Taysha Gene Therapies, INC. (TSHA) — DEFA14A Filings
All DEFA14A filings from Taysha Gene Therapies, INC.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Taysha Gene Therapies Files DEFA14A Proxy Materials
— Apr 22, 2026 Risk: low
Taysha Gene Therapies, Inc. filed a DEFA14A on April 22, 2026, related to additional definitive proxy soliciting materials. The filing includes standard DEFA14A
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX